Purpose Peripheral blood lymphopenia and elevated neutrophil-to-lymphocyte ratio (NLR)
have been associated with poor outcomes in various malignancies. However, existing …

Background Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR),
lymphocyte-to-monocyte ratio (LMR), mean platelet volume (MPV), and platelet distribution …

Purpose To evaluate whether the neutrophil-to-lymphocyte ratio (NLR) predicts survival in
patients with unresectable hepatocellular carcinoma (HCC) before and after transarterial …

Introduction: Immunotherapy is now a standard treatment for many malignancies. Although
immune checkpoint inhibition has demonstrated substantial efficacy by enhancing T cell …

Background Systemic inflammation and immune dysfunction have been proved to be
associated with cancer progression and metastasis in various malignancies. The aim of this …

Purpose A significant portion of patients with locally advanced head and neck squamous
cell carcinoma (HNSCC) relapse despite multimodality treatment denoting the need for …

Background The added value of tumoural genomic profiles to conventional clinico-biological
factors to predict progression-free survival (PFS) and overall survival (OS) was prospectively …

The COVID-19 pandemic poses a significant challenge for individuals with compromised
immune systems, such as patients with cancer, as they face a heightened susceptibility to …

In some malignant tumours, the changes in neutrophil counts in relation to other blood cells
are connected with unfavourable prognosis. Nevertheless, the prognostic value of the …

Introduction Lymphocytopenia and circulating tumor cells (CTCs) have been reported as
independent prognostic factors for overall survival (OS) in metastatic breast cancer (MBC) …